James Leroy Springer, MD | |
104 Foxborough Run, Shelbyville, IN 46176 | |
(317) 512-2711 | |
Not Available |
Full Name | James Leroy Springer |
---|---|
Gender | Male |
Speciality | Family Medicine |
Location | 104 Foxborough Run, Shelbyville, Indiana |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1194701359 | NPI | - | NPPES |
032073 | Medicaid | OR | |
1407812365 | Other | OR | NBMC GROUP NPI NUMBER |
P00143357 | Other | OR | RR MEDICARE PTAN NUMBER |
R0000WFBTV | Other | OR | MEDICARE GROUP PIN NUMBER |
201195760 | Medicaid | IN | |
CB3544 | Other | OR | RR MEDICARE GROUP NUMBER |
P01307618 | Other | IN | MEDICARE RR PTAN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | MD17476 (Oregon) | Secondary |
207Q00000X | Family Medicine | 01065737A (Indiana) | Primary |
Entity Name | Major Multispecialty Associates |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1437398492 PECOS PAC ID: 6305997842 Enrollment ID: O20090624000134 |
News Archive
Childhood cancer survivors may have an increased risk of death from other forms of cancer, cardiac and cerebrovascular causes more than 25 years after their initial illness, UK scientists have found.
The U.N. on Tuesday issued its 2012 consolidated appeal process (CAP), or joint appeal, for $1.5 billion to fund 350 projects in Somalia, "where famine and conflict have already cost tens of thousands of lives," the Guardian reports.
InSite Vision Incorporated and Senju Pharmaceutical Co., Ltd. today announced that they have entered into a collaboration and license agreement to develop and market InSite's azithromycin ophthalmic solution using DuraSite® including AzaSite® 1% and AzaSite XtraTM 2% ocular antibiotics in Japan. Senju has agreed to pay InSite an upfront license fee, additional development milestones fees, and a percentage royalty on net sales.
BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies and therapeutics, is pleased to announce that the company's therapeutic approach for treating neurodegenerative diseases was shown to be superior to other current potential stem cell treatments.
A world-first QUT study revealing light exposure plays a role in the weight of preschool children has been published by international research journal PLOS ONE.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
James Leroy Springer, MD 104 Foxborough Run, Shelbyville, IN 46176-2879 Ph: () - | James Leroy Springer, MD 104 Foxborough Run, Shelbyville, IN 46176 Ph: (317) 512-2711 |
News Archive
Childhood cancer survivors may have an increased risk of death from other forms of cancer, cardiac and cerebrovascular causes more than 25 years after their initial illness, UK scientists have found.
The U.N. on Tuesday issued its 2012 consolidated appeal process (CAP), or joint appeal, for $1.5 billion to fund 350 projects in Somalia, "where famine and conflict have already cost tens of thousands of lives," the Guardian reports.
InSite Vision Incorporated and Senju Pharmaceutical Co., Ltd. today announced that they have entered into a collaboration and license agreement to develop and market InSite's azithromycin ophthalmic solution using DuraSite® including AzaSite® 1% and AzaSite XtraTM 2% ocular antibiotics in Japan. Senju has agreed to pay InSite an upfront license fee, additional development milestones fees, and a percentage royalty on net sales.
BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies and therapeutics, is pleased to announce that the company's therapeutic approach for treating neurodegenerative diseases was shown to be superior to other current potential stem cell treatments.
A world-first QUT study revealing light exposure plays a role in the weight of preschool children has been published by international research journal PLOS ONE.
› Verified 4 days ago
Gregory J Esslinger, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2451 Intelliplex Dr Ste 260, Shelbyville, IN 46176 Phone: 317-398-0121 Fax: 317-398-0538 | |
Jarron J Lincoln, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2451 Intelliplex Dr Ste 260, Shelbyville, IN 46176 Phone: 317-398-0121 Fax: 317-398-1851 | |
Michael D Caudy, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2451 Intelliplex Dr, Ste 260, Shelbyville, IN 46176 Phone: 317-398-0121 Fax: 317-398-0538 | |
Mr. William Haehl, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 30 W Rampart St, Suite 210, Shelbyville, IN 46176 Phone: 317-398-0121 Fax: 317-398-2335 | |
Dr. Emily Ann Kapunan Andaya, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2451 Intelliplex Dr Ste 260, Shelbyville, IN 46176 Phone: 317-398-0121 | |
Beth L Buchanan, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2451 Intelliplex Dr Ste 260, Shelbyville, IN 46176 Phone: 317-398-0121 Fax: 317-398-0538 |